DOR

Dor (DOR)

Dor Biopharma

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:AMEX:DOR

일자	시간	출처	헤드라인	심볼	기업
2006/04/07	22:19	Business Wire	DOR BioPharma Announces Advances in Mucosal Vaccines for Botulinum Toxin; Antigens are Made Using Dowpharma's Pfenex Expression	AMEX:DOR	Dor Biopharma
2006/04/07	04:28	Business Wire	DOR BioPharma Announces Private Equity Financing of $3.65 Million with Institutional Investors	AMEX:DOR	Dor Biopharma
2006/03/30	23:00	Business Wire	DOR BioPharma Reports Year End 2005 Financial Results and Accomplishments; DOR Provides Guidance on Regulatory Filings on orBec	AMEX:DOR	Dor Biopharma
2006/02/08	23:25	Business Wire	DOR BioPharma Provides Financial Guidance and Update on European Regulatory Plans for orBec(R)	AMEX:DOR	Dor Biopharma
2006/01/31	07:48	Business Wire	DOR BioPharma Announces Positive Phase I Results of RiVax(TM), its Vaccine Against Ricin Toxin; Vaccine is Immunogenic and Well	AMEX:DOR	Dor Biopharma
2006/01/26	00:31	Business Wire	DOR BioPharma Achieves Manufacturing Milestone in Development of RiVax(TM); DOR and Its Collaborators Achieve 2nd Milestone Ahea	AMEX:DOR	Dor Biopharma
2006/01/20	22:10	Business Wire	DOR BioPharma Reports Positive New Survival Findings from Previously Completed Phase II and III Clinical Trials of orBec(R); Res	AMEX:DOR	Dor Biopharma
2006/01/19	23:26	Business Wire	DOR BioPharma Secures $6 Million Equity Commitment from Fusion Capital	AMEX:DOR	Dor Biopharma
2005/11/15	23:04	Business Wire	DOR BioPharma Plans FDA NDA and European MAA Filing Strategy for orBec	AMEX:DOR	Dor Biopharma
2005/11/15	06:26	Business Wire	DOR BioPharma Inc. Reports Third Quarter 2005 Financial Results and Reviews Recent Achievements; Conference Call Scheduled for N	AMEX:DOR	Dor Biopharma
2005/11/07	21:00	Business Wire	DOR BioPharma to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference	AMEX:DOR	Dor Biopharma
2005/11/02	20:00	Business Wire	DOR BioPharma Executes Letter of Intent for Acquisition of Gastrotech Pharma; Acquisition Bolsters Biotherapeutics Pipeline	AMEX:DOR	Dor Biopharma
2005/11/02	06:34	Business Wire	DOR BioPharma Receives Notice of Delisting from American Stock Exchange; Company to Continue to Negotiate Potential Compliance-A	AMEX:DOR	Dor Biopharma
2005/10/14	22:17	Business Wire	DOR BioPharma Provides Update on Programs and Corporate Matters	AMEX:DOR	Dor Biopharma
2005/09/16	06:41	PR Newswire (US)	Dr. Chris Dale, Vice President, Technology, Cambrex Biopharmaceuticals and Dr. Robert N. Brey, Chief Scientific Officer, DOR Bio	AMEX:DOR	Dor Biopharma
2005/07/27	02:07	PR Newswire (US)	DOR BioPharma and Dowpharma Enter Into a Joint Development Agreement for BT-VACC(TM), DOR's Oral Vaccine Against Botulinum Toxin	AMEX:DOR	Dor Biopharma
2005/06/15	19:30	Business Wire	DOR BioPharma, Inc. Announces Positive Interim Results from Phase I Clinical Trial of RiVax, Its Ricin Toxin Vaccine	AMEX:DOR	Dor Biopharma
2005/06/14	00:14	Business Wire	DOR BioPharma to Present at the Rodman & Renshaw Techvest 2nd Annual Security and Connectivity Conference	AMEX:DOR	Dor Biopharma
2005/05/04	23:51	Business Wire	DOR BioPharma to Present at the Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference	AMEX:DOR	Dor Biopharma
2005/05/04	23:51	Business Wire	DOR BioPharma to Present at the Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference	AMEX:DOR	Dor Biopharma
2005/05/04	21:30	Business Wire	DOR BioPharma Appoints T. Jerome Madison to Board of Directors	AMEX:DOR	Dor Biopharma
2005/05/04	21:30	Business Wire	DOR BioPharma Appoints T. Jerome Madison to Board of Directors	AMEX:DOR	Dor Biopharma
2005/01/07	22:30	PR Newswire (US)	DOR BioPharma and Cambrex Enter into a Development and Manufacturing Process Agreement for RiVax(TM)	AMEX:DOR	Dor Biopharma